Linkage to HIV care and survival following inpatient HIV counseling and testing.
Identifieur interne : 001C69 ( PubMed/Corpus ); précédent : 001C68; suivant : 001C70Linkage to HIV care and survival following inpatient HIV counseling and testing.
Auteurs : Rhoda K. Wanyenze ; Judith A. Hahn ; Cheryl A. Liechty ; Kathie Ragland ; Allan Ronald ; Harriet Mayanja-Kizza ; Thomas Coates ; Moses R. Kamya ; David R. BangsbergSource :
- AIDS and behavior [ 1573-3254 ] ; 2011.
English descriptors
- KwdEn :
- AIDS Serodiagnosis, Adult, Anti-Retroviral Agents (therapeutic use), Counseling (utilization), Female, Follow-Up Studies, HIV Infections (diagnosis), HIV Infections (drug therapy), HIV Infections (mortality), Health Services Accessibility, Humans, Inpatients (statistics & numerical data), Male, Middle Aged, Patient Acceptance of Health Care, Referral and Consultation (organization & administration), Socioeconomic Factors, Survival Analysis, Treatment Outcome, Uganda (epidemiology), Young Adult.
- MESH :
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic , epidemiology : Uganda.
- diagnosis : HIV Infections.
- drug therapy : HIV Infections.
- mortality : HIV Infections.
- organization & administration : Referral and Consultation.
- statistics & numerical data : Inpatients.
- utilization : Counseling.
- AIDS Serodiagnosis, Adult, Female, Follow-Up Studies, Health Services Accessibility, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Socioeconomic Factors, Survival Analysis, Treatment Outcome, Young Adult.
Abstract
Linkage to HIV care and survival in sub-Saharan Africa is not well documented. In 2004 we conducted a randomized trial among medical inpatients in Mulago Hospital to assess the impact of HIV counseling and testing (HCT) on linkage to care and survival. Participants were randomized to inpatient HCT (intervention) or outpatient HCT 1 week post-discharge (control); inpatient HCT was not available at Mulago during the study. Among 590 eligible patients, 85% (500) agreed to participate; 98.8% (248) in the intervention arm received HCT compared to 68.7% (171) in the control arm. Within 6 months, 62.2% (92) of surviving HIV-infected participants received HIV care; 15.0% (20) received antiretroviral medications (ARVs). Overall mortality among HIV-infected participants was 34.6% (72). HCT had significant impact on linkage to care among surviving participants. Referral for HCT was a missed opportunity for diagnosis. There is need for earlier diagnosis and linkage to HIV care among inpatients.
DOI: 10.1007/s10461-010-9704-1
PubMed: 20431933
Links to Exploration step
pubmed:20431933Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Linkage to HIV care and survival following inpatient HIV counseling and testing.</title><author><name sortKey="Wanyenze, Rhoda K" sort="Wanyenze, Rhoda K" uniqKey="Wanyenze R" first="Rhoda K" last="Wanyenze">Rhoda K. Wanyenze</name><affiliation><nlm:affiliation>Makerere University School of Public Health, Kampala, Uganda. rwanyenze@hotmail.com</nlm:affiliation></affiliation></author><author><name sortKey="Hahn, Judith A" sort="Hahn, Judith A" uniqKey="Hahn J" first="Judith A" last="Hahn">Judith A. Hahn</name></author><author><name sortKey="Liechty, Cheryl A" sort="Liechty, Cheryl A" uniqKey="Liechty C" first="Cheryl A" last="Liechty">Cheryl A. Liechty</name></author><author><name sortKey="Ragland, Kathie" sort="Ragland, Kathie" uniqKey="Ragland K" first="Kathie" last="Ragland">Kathie Ragland</name></author><author><name sortKey="Ronald, Allan" sort="Ronald, Allan" uniqKey="Ronald A" first="Allan" last="Ronald">Allan Ronald</name></author><author><name sortKey="Mayanja Kizza, Harriet" sort="Mayanja Kizza, Harriet" uniqKey="Mayanja Kizza H" first="Harriet" last="Mayanja-Kizza">Harriet Mayanja-Kizza</name></author><author><name sortKey="Coates, Thomas" sort="Coates, Thomas" uniqKey="Coates T" first="Thomas" last="Coates">Thomas Coates</name></author><author><name sortKey="Kamya, Moses R" sort="Kamya, Moses R" uniqKey="Kamya M" first="Moses R" last="Kamya">Moses R. Kamya</name></author><author><name sortKey="Bangsberg, David R" sort="Bangsberg, David R" uniqKey="Bangsberg D" first="David R" last="Bangsberg">David R. Bangsberg</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:20431933</idno><idno type="pmid">20431933</idno><idno type="doi">10.1007/s10461-010-9704-1</idno><idno type="wicri:Area/PubMed/Corpus">001C69</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C69</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Linkage to HIV care and survival following inpatient HIV counseling and testing.</title><author><name sortKey="Wanyenze, Rhoda K" sort="Wanyenze, Rhoda K" uniqKey="Wanyenze R" first="Rhoda K" last="Wanyenze">Rhoda K. Wanyenze</name><affiliation><nlm:affiliation>Makerere University School of Public Health, Kampala, Uganda. rwanyenze@hotmail.com</nlm:affiliation></affiliation></author><author><name sortKey="Hahn, Judith A" sort="Hahn, Judith A" uniqKey="Hahn J" first="Judith A" last="Hahn">Judith A. Hahn</name></author><author><name sortKey="Liechty, Cheryl A" sort="Liechty, Cheryl A" uniqKey="Liechty C" first="Cheryl A" last="Liechty">Cheryl A. Liechty</name></author><author><name sortKey="Ragland, Kathie" sort="Ragland, Kathie" uniqKey="Ragland K" first="Kathie" last="Ragland">Kathie Ragland</name></author><author><name sortKey="Ronald, Allan" sort="Ronald, Allan" uniqKey="Ronald A" first="Allan" last="Ronald">Allan Ronald</name></author><author><name sortKey="Mayanja Kizza, Harriet" sort="Mayanja Kizza, Harriet" uniqKey="Mayanja Kizza H" first="Harriet" last="Mayanja-Kizza">Harriet Mayanja-Kizza</name></author><author><name sortKey="Coates, Thomas" sort="Coates, Thomas" uniqKey="Coates T" first="Thomas" last="Coates">Thomas Coates</name></author><author><name sortKey="Kamya, Moses R" sort="Kamya, Moses R" uniqKey="Kamya M" first="Moses R" last="Kamya">Moses R. Kamya</name></author><author><name sortKey="Bangsberg, David R" sort="Bangsberg, David R" uniqKey="Bangsberg D" first="David R" last="Bangsberg">David R. Bangsberg</name></author></analytic><series><title level="j">AIDS and behavior</title><idno type="eISSN">1573-3254</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS Serodiagnosis</term><term>Adult</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>Counseling (utilization)</term><term>Female</term><term>Follow-Up Studies</term><term>HIV Infections (diagnosis)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (mortality)</term><term>Health Services Accessibility</term><term>Humans</term><term>Inpatients (statistics & numerical data)</term><term>Male</term><term>Middle Aged</term><term>Patient Acceptance of Health Care</term><term>Referral and Consultation (organization & administration)</term><term>Socioeconomic Factors</term><term>Survival Analysis</term><term>Treatment Outcome</term><term>Uganda (epidemiology)</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Uganda</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Referral and Consultation</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Inpatients</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Counseling</term></keywords><keywords scheme="MESH" xml:lang="en"><term>AIDS Serodiagnosis</term><term>Adult</term><term>Female</term><term>Follow-Up Studies</term><term>Health Services Accessibility</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Acceptance of Health Care</term><term>Socioeconomic Factors</term><term>Survival Analysis</term><term>Treatment Outcome</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Linkage to HIV care and survival in sub-Saharan Africa is not well documented. In 2004 we conducted a randomized trial among medical inpatients in Mulago Hospital to assess the impact of HIV counseling and testing (HCT) on linkage to care and survival. Participants were randomized to inpatient HCT (intervention) or outpatient HCT 1 week post-discharge (control); inpatient HCT was not available at Mulago during the study. Among 590 eligible patients, 85% (500) agreed to participate; 98.8% (248) in the intervention arm received HCT compared to 68.7% (171) in the control arm. Within 6 months, 62.2% (92) of surviving HIV-infected participants received HIV care; 15.0% (20) received antiretroviral medications (ARVs). Overall mortality among HIV-infected participants was 34.6% (72). HCT had significant impact on linkage to care among surviving participants. Referral for HCT was a missed opportunity for diagnosis. There is need for earlier diagnosis and linkage to HIV care among inpatients.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20431933</PMID><DateCreated><Year>2011</Year><Month>04</Month><Day>26</Day></DateCreated><DateCompleted><Year>2011</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-3254</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>AIDS and behavior</Title><ISOAbbreviation>AIDS Behav</ISOAbbreviation></Journal><ArticleTitle>Linkage to HIV care and survival following inpatient HIV counseling and testing.</ArticleTitle><Pagination><MedlinePgn>751-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10461-010-9704-1</ELocationID><Abstract><AbstractText>Linkage to HIV care and survival in sub-Saharan Africa is not well documented. In 2004 we conducted a randomized trial among medical inpatients in Mulago Hospital to assess the impact of HIV counseling and testing (HCT) on linkage to care and survival. Participants were randomized to inpatient HCT (intervention) or outpatient HCT 1 week post-discharge (control); inpatient HCT was not available at Mulago during the study. Among 590 eligible patients, 85% (500) agreed to participate; 98.8% (248) in the intervention arm received HCT compared to 68.7% (171) in the control arm. Within 6 months, 62.2% (92) of surviving HIV-infected participants received HIV care; 15.0% (20) received antiretroviral medications (ARVs). Overall mortality among HIV-infected participants was 34.6% (72). HCT had significant impact on linkage to care among surviving participants. Referral for HCT was a missed opportunity for diagnosis. There is need for earlier diagnosis and linkage to HIV care among inpatients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wanyenze</LastName><ForeName>Rhoda K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Makerere University School of Public Health, Kampala, Uganda. rwanyenze@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>Judith A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Liechty</LastName><ForeName>Cheryl A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Ragland</LastName><ForeName>Kathie</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ronald</LastName><ForeName>Allan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mayanja-Kizza</LastName><ForeName>Harriet</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Coates</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kamya</LastName><ForeName>Moses R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Bangsberg</LastName><ForeName>David R</ForeName><Initials>DR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH054907</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 MH087227</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH077512-05</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24-MH087227</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH077512-01A1</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH077512-04</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH077512-02</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH077512</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH077512-03</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AIDS Behav</MedlineTA><NlmUniqueID>9712133</NlmUniqueID><ISSNLinking>1090-7165</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2000 Jul 8;356(9224):103-12</RefSource><PMID Version="1">10963246</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Patient Care STDS. 2010 Feb;24(2):117-26</RefSource><PMID Version="1">20059356</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2001 May 25;15(8):1045-52</RefSource><PMID Version="1">11399987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Recomm Rep. 2001 Nov 9;50(RR-19):1-57; quiz CE1-19a1-CE6-19a1</RefSource><PMID Version="1">11718472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):106-14</RefSource><PMID Version="1">12352157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):62-6</RefSource><PMID Version="1">14501795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2004 Apr;82(4):299-307</RefSource><PMID Version="1">15259260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1991 Jan;5(1):61-7</RefSource><PMID Version="1">2059362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1992 Jun 20;304(6842):1605-9</RefSource><PMID Version="1">1628088</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1994 Aug;8(8):1169-71</RefSource><PMID Version="1">7986417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tidsskr Nor Laegeforen. 1995 Oct 30;115(26):3286-8</RefSource><PMID Version="1">7482463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 1999 Feb;11(1):87-93</RefSource><PMID Version="1">10434985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2006 Jan;84(1):52-7</RefSource><PMID Version="1">16501715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Behav. 2006 Jul;10(4):361-7</RefSource><PMID Version="1">16395619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4</RefSource><PMID Version="1">16988643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Behav. 2007 Sep;11(5):753-8</RefSource><PMID Version="1">17096199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2007 Jul;85(7):550-4</RefSource><PMID Version="1">17768504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Afr Health Sci. 2007 Sep;7(3):124-8</RefSource><PMID Version="1">18052863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2008 Apr;86(4):302-9</RefSource><PMID Version="1">18438519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2008 Jul;86(7):559-67</RefSource><PMID Version="1">18670668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Oct 1;22(15):1897-908</RefSource><PMID Version="1">18784453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2009 Jan 28;23(3):395-401</RefSource><PMID Version="1">19114865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):280-9</RefSource><PMID Version="1">19521248</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2000 Nov;31(5):1258-65</RefSource><PMID Version="1">11073761</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015492" MajorTopicYN="N">AIDS Serodiagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003376" MajorTopicYN="N">Counseling</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014454" MajorTopicYN="N" Type="Geographic">Uganda</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">NIHMS272406</OtherID><OtherID Source="NLM">PMC3082586</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20431933</ArticleId><ArticleId IdType="doi">10.1007/s10461-010-9704-1</ArticleId><ArticleId IdType="pmc">PMC3082586</ArticleId><ArticleId IdType="mid">NIHMS272406</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C69 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001C69 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:20431933
|texte= Linkage to HIV care and survival following inpatient HIV counseling and testing.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:20431933" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |